Navigation Links
Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
Date:3/28/2011

CINCINNATI, March 28, 2011 /PRNewswire/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced several of its executives will speak on key industry issues at the 20th Annual Partnerships in Clinical Trials Conference March 30 to April 1, 2011, in Phoenix, Ariz. Kendle experts will address the impact of pharma industry mergers and acquisitions on outsourcing strategies as well as best practices for patient recruitment and retention.  Kendle also will host a "Quiz our Experts" interactive Q&A session March 31 from 3:45 to 4:15 p.m. in Booth #301 on the showroom floor to address questions and share insights with customers on key clinical development issues.

Participating on the executive panel "Sponsors and CROs Unplugged – Assess the Impact of M&A On Your Outsourcing Strategy" on Thursday, March 31 at 11:45 a.m. will be Stephen Cutler, PhD, Kendle's current Senior Vice President and Chief Operating Officer who will assume the role of President and Chief Executive Officer on May 1. With more than 20 years of senior management and operations leadership experience in the CRO and biopharmaceutical industries, Dr. Cutler has extensive experience in the development and delivery of successful partnerships between CROs and their customers (for a recent interview with Dr. Cutler in Pharmaceutical Outsourcing on how strategic partnerships with CROs can lead  to  more  cost-effective clinical development efforts, please visit http://www.kendle.com/uploads/PharmaOutsourcing0311_Cutler.pdf).

Also representing Kendle at the conference will be Jeff Zucker, Senior Director and Global Head, Patient Recruitment on the topic of best practices in patient recruitment; as well as a panel of Kendle executives featuring Mr. Zucker; Mark Roseman, DSc, Senior Vice President, Sales and Chief Marketing Officer; and Thomas O'Donnell, Vice President, Strategic Alliances, moderated by John Macdonald, Vice President, New Business Development – Europe and Asia/Pacific. Kendle Speakers at Partnerships in Clinical TrialsThursday, March 31, 11:45 a.m.  – Track SSponsors and CROs Unplugged – Assess the Impact of M&A On Your Outsourcing StrategyStephen Cutler, PhDSenior Vice President and Chief Operating OfficerThursday, March 31, 3:45 – 4:15 p.m. – Kendle Booth #301Quiz Our ExpertsModerator: John Macdonald, Vice President, New Business Development – Europe and Asia/PacificPanelists: Mark Roseman, DSc, Senior Vice President, Sales and Chief Marketing Officer; Thomas O'Donnell, Vice President, Strategic Alliances; and Jeff Zucker, Senior Director and Global Head, Patient RecruitmentFriday, April 1, 11:45 a.m. – Track OBest Practices for Patient Recruitment and Retention in Clinical TrialsJeff ZuckerSenior Director and Global Head, Patient RecruitmentVisit Kendle at Booth #301Kendle speakers and additional senior clinical development experts will be available at Booth #301 for on-site meetings and to discuss the Company's approach to successful partnerships – focusing on quality, delivery and efficiency to bring greater innovation and value to the clinical development process.

About KendleKendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's website at www.kendle.com.


'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Announces Fourth Quarter and Full-Year 2010 Results
2. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
3. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
4. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
5. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
6. Kendle Appoints Mark J. Roseman, D.Sc., Senior Vice President and Chief Marketing Officer
7. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
8. Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
9. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
10. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
11. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 /PRNewswire/ - InMed Pharmaceuticals, Inc. ... on its R&D program in the use of ... disease (COPD). In June, 2015 InMed initiated its ... identify the targets and potential active compounds that ... Subsequently, with in vitro assays using human lung ...
(Date:12/5/2016)... -- Balloon catheter is an innovative medical device that comprises ... artery in the leg or sometimes into the radial ... These products are generally used to prevent blood vessel ... substances in the blood vessel. In terms of revenue, ... at a CAGR of 3.8% during the forecast period ...
(Date:12/5/2016)... 5, 2016 Spain Glaucoma Surgery Devices Market ... "Spain Glaucoma Surgery Devices Market Outlook to 2022", provides ... market. The report provides value, in millions of US ... market segements - Canaloplasty Micro Catheters and Glaucoma Drainage ... distribution shares data for each of these market segements, ...
Breaking Medicine Technology:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the impact of new federal healthcare regulations at the 7th annual Health IT ... Atlanta. , Andy Slavitt, acting administrator for the Centers for Medicare & Medicaid ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... ... 2016 , ... 'Tis the season for family, festivity, food and fun! Temptation ... season when eating healthy, staying active, and taking medication and doing daily foot health ... , "Shopping trips, parties and family gatherings can take their toll on our ...
(Date:12/6/2016)... ... December 06, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has announced the addition of ... safety and health training to public sector employees. , “The primary goal of ...
(Date:12/5/2016)... ... December 05, 2016 , ... Edward Buckingham MD , ... arrival of the newest Sciton laser in January 2017. The Halo is the ... and ablative wavelengths for exceptional results. Outperforming more traditional lasers, the innovative Halo ...
Breaking Medicine News(10 mins):